113 related articles for article (PubMed ID: 11083992)
21. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
23. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
24. [Epoprostenol in the treatment of portopulmonary hypertension].
Culafić D; Culafić-Vojinović V; Jesić R
Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
[TBL] [Abstract][Full Text] [Related]
25. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
Bendayan D; Fink G; Aravot D; Ygla M; Bendov I; Bliden L; Nir A; Kramer MR
Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
[TBL] [Abstract][Full Text] [Related]
26. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery.
Bildirici I; Shumway JB
Obstet Gynecol; 2004 May; 103(5 Pt 2):1102-5. PubMed ID: 15121623
[TBL] [Abstract][Full Text] [Related]
27. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
Andreassen AK; Madsen S; Kjekshus J; Simonsen S
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
[TBL] [Abstract][Full Text] [Related]
28. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Laohaprasitiporn D; Soongswang J; Chanthong P; Nana A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S60-5. PubMed ID: 16856428
[TBL] [Abstract][Full Text] [Related]
30. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
31. Primary pulmonary hypertension. World Health Organization.
Fauzi AR
Med J Malaysia; 2000 Dec; 55(4):529-37; quiz 538. PubMed ID: 11221172
[TBL] [Abstract][Full Text] [Related]
32. Nebulized nitroglycerin in children with pulmonary hypertension secondary to congenital heart disease.
Omar HA; Gong F; Sun MY; Einzig S
W V Med J; 1999; 95(2):74-5. PubMed ID: 10214095
[TBL] [Abstract][Full Text] [Related]
33. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
34. Intraoperative epoprostenol and nitric oxide for severe pulmonary hypertension during orthotopic liver transplantation: a case report and review of the literature.
Vater Y; Martay K; Dembo G; Bowdle TA; Weinbroum AA
Med Sci Monit; 2006 Dec; 12(12):CS115-118. PubMed ID: 17136012
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature.
Tam DH; Farber HW
Am J Hematol; 2006 Jun; 81(6):443-7. PubMed ID: 16680745
[TBL] [Abstract][Full Text] [Related]
36. [Perioperative management of living-donor liver transplantation in two patients with severe portopulmonary hypertension].
Tominaga M; Furutani H; Segawa H; Shoda T; Mima H; Adachi T; Fukuda K
Masui; 2003 Jul; 52(7):729-32. PubMed ID: 12910972
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
Desole S; Velik-Salchner C; Fraedrich G; Ewert R; Kähler CM
Heart Lung; 2012; 41(6):599-605. PubMed ID: 22920608
[TBL] [Abstract][Full Text] [Related]
38. [A case of rapidly progressive pulmonary pulmonary hypertension in a 14-year-old girl].
Yasui K; Mashimo K; Saiki K; Maki T; Niimura I
Kokyu To Junkan; 1989 Sep; 37(9):1021-5. PubMed ID: 2595131
[TBL] [Abstract][Full Text] [Related]
39. [Primary pulmonary hypertension in children].
Hankø E; Hågå P
Tidsskr Nor Laegeforen; 1999 Feb; 119(4):512-4. PubMed ID: 10081374
[TBL] [Abstract][Full Text] [Related]
40. [Quality of life perception by women suffering from stage III or IV primary pulmonary hypertension and receiving prostacyclin treatment].
Péloquin J; Robichaud-Ekstrand S; Pepin J
Can J Nurs Res; 1998; 30(1):113-36. PubMed ID: 9726186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
